Therapeutic drug monitoring in depression

Polish Journal of Pharmacology

Volumn 52, Issue 4, 2000, Pages 255-266

  Radziwon Zaleska, M ^a   Matsumoto, H ^a   Skalski, M ^a   Androsiuk, W ^a   Dziklinska, A ^a   Kunicki, P K ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Major depression; Pharmacoelectroencephalography; Pharmacogenetics; Therapeutic drug monitoring; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DEBRISOQUINE; DESIPRAMINE; IMIPRAMINE; NEUROLEPTIC AGENT; NORCLOMIPRAMINE; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; ELECTROENCEPHALOGRAM; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEALTH STATUS; HUMAN; HYDROXYLATION; LABORATORY DIAGNOSIS; MALE; PHARMACOGENETICS; PHENOTYPE; PREDICTION; PROGNOSIS; PSYCHOPHARMACOTHERAPY; RATING SCALE; SIDE EFFECT; TREATMENT PLANNING;

ADRENERGIC AGENTS; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEALKYLATION; DEBRISOQUIN; DEPRESSIVE DISORDER; DRUG MONITORING; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES;

EID: 0033754146     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Therapeutic Drug Monitoring (Polish)
2. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
3. Clinical research in psychopharmacology
4. Polymorphic drug oxidation. Relevance to the treatment of psychiatric disorders
5. Short-term treatment of mood disorders with standard antidepressants
6. Genetic determinations to drug responsiveness and drug interactions
7. Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics
8. Metabolism of psychotropic drugs: Pharmacological and clinical relevance
9. The genetic polymorphism of debrisoquine/sparteine metabolism - Clinical aspects
10. Therapeutic drug monitoring for the treatment of psychiatric disorders
11. A comparison of high-performance liquid chromatography and fluorescence polarization immunoassay for therapeutic drug monitoring of tricyclic antidepressants
12. Pharmaco-EEG: Computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans
13. Debrisoquine hydroxylation in a Polish population
14. On some hypothesis underlying pharmacoencephalography
15. Debrisoquine and mephenytion hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptics and antidepressive agents
16. Antidepressants and drug-metabolizing enzymes - Expert group report
17. High-performance liquid chromatography of clomipramine and metabolites in human plasma and urine
18. Therapeutic monitoring of antidepressant drugs: Guidelines updated
19. Tricyclic antidepressant plasma level monitoring: An improvement over dose-response approach
20. Pharmacokinetics of antidepressants: Why and how they are relevant to treatment
21. Therapeutic Drug Monitoring in Depression (Polish)
22. Pharmaco-EEG profiles of typical and atypical antidepressants
23. Application of pharmaco-EEG in monitored therapy during depression (Polish)
24. Polymorphic debrysoquin hydroxylation in 757 Swedish subjects
25. Clinical usefulness of imipramine and desipramine serum-level monitoring in patients treated for endogenous depression
26. Debrysoquine hydroxylation phenotypes of patients with high versus normal serum antidepressant concentration
27. Task Force on the use of laboratory tests in psychiatry: Tricyclic antidepressants - Blood level measurement and clinical outcome
28. Introduction to psychoactive drugs. Tricyclic Antidepressants